Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery U-PLEX Human I-TAC ASY384-well
SDP

Catalog No. 5000080701
Encompass

The U-PLEX Human I-TAC Assay from Meso Scale Discovery is a multiplex immunoassay that measures Interferon-inducible T-cell Alpha Chemoattractant (I-TAC) in human serum plasma and cell culture supernatants This assay utilizes MSD s electrochemiluminescent detection technology and provides high sensitivity up to 5-logs of dynamic range and low sample volume requirements The kit includes a 96-well plate pre-coated with capture antibodies detection antibodies and calibrators to generate a standard curve Results are obtained in as little as 3 5 hours using an MSD instrument This assay allows for the rapid accurate quantification of I-TAC

Catalog No. 50-000-80701 Supplier Meso Scale Discovery Supplier No. K251UWK2
May include imposed supplier surcharges.
Add to Cart
Add to Cart
Request a Quote

missing translation for 'validMainframeMsg'

The U-PLEX Human I-TAC Assay from Meso Scale Discovery is a multiplex immunoassay that measures Interferon-inducible T-cell Alpha Chemoattractant (I-TAC) in human serum plasma and cell culture supernatants This assay utilizes MSD s electrochemiluminescent detection technology and provides high sensitivity up to 5-logs of dynamic range and low sample volume requirements The kit includes a 96-well plate pre-coated with capture antibodies detection antibodies and calibrators to generate a standard curve Results are obtained in as little as 3 5 hours using an MSD instrument This assay allows for the rapid accurate quantification of I-TAC

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.